Physician profile
Stacy D Boyd
NPI 1205930864
$3,720.16
in general payments reported to CMS, 2019-2025
26 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2020: $336 · 2021: $601 · 2022: $946 · 2023: $671 · 2024: $596 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,470.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,203.34 | 2021-2025 | Symplicity G3, Onyx Frontier, Telescope |
| Abbvie INC. | $541.19 | 2019-2024 | Lo Loestrin Fe, Liletta, Orilissa |
| Daiichi Sankyo INC. | $353.34 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $294.60 | 2021-2024 | |
| Astellas Pharma US INC | $265.91 | 2019-2025 | Veozah |
| Organon LLC | $169.40 | 2021-2024 | |
| Myovant Sciences INC. | $122.43 | 2021-2022 | |
| Hologic Sales and Service, LLC | $108.27 | 2020-2024 | Thinprep 2000 Processor, Aptima, Novasure |
| Mylan Pharmaceuticals INC. | $89.61 | 2019-2021 | |
| Allergan, INC. | $79.14 | 2019-2020 | |
| Pfizer INC. | $50.74 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $46.15 | 2024 | Myfembree, Gemtesa |
| Urovant Sciences INC | $43.11 | 2021 | |
| Roche Diagnostics Corporation | $42.97 | 2019 | |
| Ethicon US, LLC | $39.47 | 2022-2025 | Stratafix, Ethicon, Surgicel Nu-Knit |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $37.74 | 2019-2023 | On-Q* Pump and Accessories |
| Therapeuticsmd, INC. | $36.04 | 2022 | |
| Gynesonics, INC. | $35.34 | 2022 | |
| Smith+Nephew, INC. | $31.87 | 2023-2025 | Pico |
| Merck Sharp & Dohme LLC | $30.68 | 2021 | |
| Boston Scientific Corporation | $20.87 | 2019 | |
| Conmed Corporation | $19.19 | 2025 | Vcare |
| Exeltis, USA INC. | $18.37 | 2025 | Slynd |
| Avion Pharmaceuticals | $13.84 | 2020 | |
| Aspira Women'S Health INC | $13.35 | 2020 | |
| Sage Therapeutics, LLC | $13.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.